Design (Testphase)
Breakout & Setup
ATH
134
Hits
July 21, 2026
last calculated
Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · showing the 25 strongest hits
All-Time High: shows stocks currently trading at their all-time high — no more than 2% below it. The all-time high is measured over the complete available price history (as far back as data exists, currently to 2021). Stocks above their all-time high have no old price resistance left overhead; every holder is in the green. A classic strength signal — related to the Green Line Breakout, but without the strict 3-month consolidation requirement.
Global filters: 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.
🔔 Watch scanner
Terms in This Scanner Explained
(16)
- ADR (Average Daily Range)
- The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
- AI Classification
- Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
- Analysis (Full Company Analysis)
- If the Analysis column shows "Read," there is an in-depth Minnow Street company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
- Avg/Yr 3Y (Average Annual Return)
- The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
- Breakout
- The price clears a level where it previously failed multiple times (top of a base, an old high) - ideally on clearly elevated volume. For many momentum strategies, the breakout is the actual buy signal.
- Earnings Date
- The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
- EPS (Earnings per Share)
- Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
- Free Cash Flow (FCF)
- Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
- Funda Rating (Fundamental Rating A+ to F)
- Our proprietary fundamental rating from -100 to +100 with a school-grade rank from A+ to F. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. A/A+ are the fundamentally strongest stocks in the universe.
- Market Capitalization (Mkt Cap)
- The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run.
- Net Margin
- How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
- Operating Cash Flow (OCF)
- The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
- Piotroski F-Score
- A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
- Sector & Industry
- Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
- Stage (Weinstein Stages 1-4)
- Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.
- Stress RS (Strength on Stress Days)
- A stress day is a day on which both the overall market and the stock's own sector fell at least 0.5%. Stress RS counts on how many of these days the stock still closed green (shown as "g/n" = green days out of n stress days) and turns that into a rating from 1 to 99. High values point to buyers stepping in even on weak days - often a sign of institutional accumulation.
Hit List
Filter ▾
Rating (traffic light)
Stage
Funda Rating
Piotroski
Columns ▾
This scanner's columns
Extra columns
Tip: clicking a column header sorts the table by that column; a second click flips the direction.
| Symbol | Earnings | Avg/Y 3Y | Stress RS | Stage | Funda Rating | Piotroski | MktCap | Industry | AI Rating | Deep Dive | Deep-Dive Report | Sector | Price | YTD | 6 Mo. | 1 Year | Off High | Price Target | RS | EPS Rating | ADR 10D | ADR 30D | Beta | P/E | P/E (f) | P/S | P/B | P/FCF | PEG | EV/EBITDA | EBIT Margin | Gross Margin | Net Margin | ROE | ROA | Debt/Eq | Equity Ratio | Sales +/Y | Div. Yield | Payout Ratio | Altman Z | Inst. % | Short % | Analysts |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LQDA Liquidia Technologies Inc | 08/11 | +241 % | 93 9/22 | Stage 2 | B +50 | 7 of 9 | 6.8 | Drug Manufacturers - Special | Neutral | — | — | Healthcare | 77.10 $ | +114.7 % | +109.9 % | +469.7 % | −1.7 % | -3.5 % | 98 | 42 | 6.2 % | 6.4 % | 0.55 | 459.8 | 38.0 | 23.7 | 64.0 | 165.9 | — | 129.8 | 46.3 % | 91.8 % | 7.7 % | 28.2 % | 9.0 % | 1.70 | 27.0 % | +1,031.2 % | 0.0 % | 0.0 % | 2.9 | 70.2 % | 16.2 % | 1.2 (10) |
| ATROB Astronics Corp Cl B | 07/30 | +130 % | — | Stage 2 | B +20 | 6 of 9 | 0.0 | Aerospace & Defense | – | — | — | Industrials | 67.00 $ | +81.9 % | +204.6 % | +450.2 % | −9.8 % | — | 98 | 50 | 9.3 % | 6.4 % | 1.13 | 83.8 | 27.1 | — | 26.1 | — | 1.45 | 34.3 | — | 31.4 % | 5.1 % | 21.2 % | 9.0 % | 2.34 | — | +8.4 % | 0.0 % | 0.0 % | 7.9 | 11.0 % | — | — |
| ALOT AstroNova Inc | — | +30 % | 95 11/25 | Stage 2 | C +3 | 9 of 9 | 0.2 | Computer Hardware | – | — | — | Technology | 28.70 $ | +228.3 % | +249.6 % | +214.4 % | −0.8 % | -8.6 % | 98 | 81 | 8.8 % | 6.2 % | 0.86 | — | 14.0 | 1.5 | — | 22.1 | — | 38.6 | — | 33.8 % | -0.9 % | -1.8 % | 2.6 % | — | — | -0.5 % | 0.0 % | 0.0 % | 7.3 | 44.9 % | 0.2 % | — |
| RVMD Revolution Medicines Inc | 08/05 | +188 % | 38 4/22 | Stage 2 | D -18 | 1 of 9 | 37.1 | Biotechnology | – | — | — | Healthcare | 180.40 $ | +112.8 % | +137.2 % | +324.0 % | −3.4 % | +10.7 % | 97 | 42 | 4.8 % | 4.4 % | 1.38 | — | 0.0 | — | 25.8 | — | — | -9.7 | 0.0 % | -151,691.8 % | 0.0 % | -76.7 % | -37.5 % | 0.29 | 66.6 % | -100.0 % | 0.0 % | 0.0 % | 1.4 | 95.7 % | 6.1 % | 1.0 (12) |
| MBX MBX Biosciences, Inc. Common Stock | 08/06 | — | 69 6/22 | Stage 2 | D -33 | 3 of 9 | 2.3 | Biotechnology | – | — | — | Healthcare | 60.10 $ | +47.1 % | +67.7 % | +397.4 % | −4.1 % | +37.2 % | 97 | 42 | 8.5 % | 7.7 % | — | — | 0.0 | — | 5.5 | — | — | 0.0 | 0.0 % | — | 0.0 % | -25.7 % | -17.7 % | 0.00 | 96.7 % | — | 0.0 % | 0.0 % | 37.2 | 111.5 % | 16.8 % | 1.0 (5) |
| APGE Apogee Therapeutics, Inc. Common S | 08/10 | — | 68 6/22 | Stage 2 | D -30 | 4 of 9 | 10.0 | Biotechnology | – | — | — | Healthcare | 134.20 $ | +76.0 % | +69.8 % | +220.9 % | −0.4 % | -1.6 % | 96 | 42 | 6.7 % | 6.5 % | 0.33 | — | 0.0 | — | 7.9 | — | — | 0.0 | 0.0 % | — | 0.0 % | -28.5 % | -19.0 % | 0.01 | 97.1 % | — | 0.0 % | 0.0 % | 40.3 | 131.6 % | 22.0 % | 1.0 (9) |
| SPHR Sphere Entertainment Co. | 08/06 | +158 % | — | Stage 2 | B +17 | 9 of 9 | 0.0 | Entertainment | Uses AI | — | Communication Services | 137.50 $ | +66.4 % | +83.4 % | +279.5 % | −0.4 % | +5.6 % | 95 | 50 | 4.7 % | 4.8 % | 1.60 | 57.2 | 28.4 | — | 2.7 | — | — | 11.6 | 2.7 % | 55.1 % | 8.6 % | 5.5 % | -1.0 % | 0.42 | 53.2 % | +0.0 % | 0.0 % | 0.0 % | 4.9 | 130.0 % | 37.2 % | 1.5 (10) | |
| NVCT Nuvectis Pharma Inc | 08/04 | +1 % | 82 7/22 | Stage 2 | E -54 | 1 of 9 | 0.9 | Biotechnology | – | — | — | Healthcare | 18.00 $ | +132.5 % | +270.0 % | +207.5 % | −0.2 % | +4.8 % | 95 | 42 | 16.4 % | 9.8 % | -0.25 | — | 0.0 | — | — | — | — | -7.4 | — | — | 0.0 % | -154.4 % | -63.6 % | — | — | -100.0 % | 0.0 % | 0.0 % | -7.1 | 18.2 % | 10.1 % | — |
| BTSG BrightSpring Health Services, Inc. | 08/07 | — | 88 8/22 | Stage 2 | B +49 | 8 of 9 | 13.8 | Health Information Services | – | — | — | Healthcare | 70.50 $ | +78.5 % | +82.8 % | +196.9 % | −0.2 % | -3.9 % | 94 | 94 | 3.0 % | 3.3 % | 1.80 | 89.6 | 38.3 | 1.0 | 6.8 | 33.4 | — | 29.4 | 3.4 % | 12.2 % | 2.3 % | 9.2 % | 4.1 % | -4.87 | 31.9 % | +14.6 % | 0.0 % | 0.0 % | 5.5 | 101.5 % | 7.5 % | 1.1 (12) |
| BHE Benchmark Electronics Inc | 07/29 | +95 % | 87 9/25 | Stage 2 | C +7 | 8 of 9 | 3.5 | Electronic Components | Neutral | — | Technology | 80.60 $ | +113.2 % | +113.5 % | +148.1 % | −1.3 % | -19.7 % | 94 | 92 | 5.0 % | 4.8 % | 1.26 | 97.9 | 14.1 | 1.3 | 3.2 | 40.1 | 1.33 | 22.3 | 3.8 % | 10.2 % | 1.3 % | 3.1 % | 2.9 % | 0.28 | 52.3 % | +0.1 % | 0.8 % | 27.6 % | 8.1 | 107.4 % | 4.7 % | 1.3 (3) | |
| SEPN Septerna, Inc. Common Stock | 08/10 | — | — | Stage 2 | C -4 | 4 of 9 | 0.0 | Biotechnology | – | — | — | Healthcare | 32.20 $ | +31.2 % | +17.9 % | +242.4 % | −9.1 % | +30.3 % | 94 | 50 | 7.5 % | 6.9 % | — | — | 107.5 | — | — | — | — | 0.0 | — | 100.0 % | -49.9 % | -9.3 % | -8.5 % | — | — | +4,174.5 % | 0.0 % | 0.0 % | 7.0 | 102.7 % | 11.7 % | — |
| AVR Anteris Technologies Global Corp. Common Stock | 08/10 | — | 70 6/22 | Stage 2 | D -38 | 4 of 9 | 1.0 | Medical Instruments & Supplies | – | — | — | Healthcare | 8.20 $ | +106.0 % | +80.8 % | +173.7 % | −6.4 % | +55.2 % | 94 | 42 | 6.4 % | 6.9 % | 0.73 | — | 0.0 | 533.9 | — | — | — | 0.0 | — | 74.3 % | 0.0 % | -59.2 % | -34.0 % | — | — | -29.2 % | 0.0 % | 0.0 % | 20.7 | 66.1 % | 8.3 % | — |
| CRS Carpenter Technology Corporation | 07/30 | +349 % | 76 9/29 | Stage 2 | B +37 | 8 of 9 | 29.8 | Metal Fabrication | Neutral | — | Industrials | 555.10 $ | +83.8 % | +81.7 % | +122.9 % | −1.0 % | -18.4 % | 93 | 77 | 3.8 % | 4.1 % | 1.22 | 62.1 | 23.4 | 9.8 | 14.4 | 73.1 | 1.59 | 38.3 | 22.8 % | 29.7 % | 15.8 % | 24.9 % | 11.3 % | 0.38 | 56.2 % | +4.3 % | 0.1 % | 8.2 % | 10.1 | 97.9 % | 3.9 % | 1.1 (9) | |
| TRVI Trevi Therapeutics Inc | 08/06 | +178 % | 55 5/22 | Stage 2 | D -47 | 3 of 9 | 2.6 | Biotechnology | – | — | — | Healthcare | 16.80 $ | +38.8 % | +43.6 % | +204.7 % | −0.9 % | +32.8 % | 93 | 42 | 6.1 % | 5.0 % | 1.00 | — | 0.0 | — | — | — | — | -4.9 | 0.0 % | — | 0.0 % | -33.6 % | -23.0 % | — | 95.8 % | — | 0.0 % | 0.0 % | 25.7 | 98.3 % | 11.2 % | 1.0 (8) |
| ALNT Allient Inc. | 08/05 | +50 % | — | Stage 2 | B +19 | 7 of 9 | 0.0 | Electronic Components | Neutral | — | Technology | 86.60 $ | +78.9 % | +77.1 % | +183.8 % | −2.3 % | -27.8 % | 93 | 50 | 6.4 % | 6.4 % | 1.59 | 68.3 | 34.1 | — | 5.4 | — | — | 23.8 | 7.3 % | 32.9 % | 4.3 % | 8.2 % | 5.1 % | 0.65 | 53.0 % | +4.6 % | 0.2 % | 5.9 % | 8.4 | 78.8 % | 5.5 % | 1.3 (3) | |
| CTOS Custom Truck One Source Inc | 07/29 | +23 % | 59 7/29 | Stage 2 | B +18 | 7 of 9 | 2.8 | Rental & Leasing Services | – | — | — | Industrials | 10.30 $ | +95.3 % | +99.5 % | +136.0 % | −2.1 % | -3.9 % | 93 | 21 | 4.8 % | 4.3 % | 1.35 | — | 67.1 | 1.4 | 3.4 | — | — | 11.4 | — | 21.7 % | -0.9 % | -2.2 % | 2.8 % | 3.09 | — | +7.9 % | 0.0 % | 0.0 % | 3.8 | 97.0 % | 4.2 % | — |
| IESC IES Holdings Inc | 08/07 | +416 % | 59 7/29 | Stage 2 | A +58 | 6 of 9 | 16.2 | Engineering & Construction | Neutral | — | — | Industrials | 621.00 $ | +82.6 % | +77.9 % | +165.6 % | −4.7 % | -8.7 % | 92 | 79 | 7.0 % | 6.3 % | 1.78 | 38.2 | 208.3 | 4.5 | 13.3 | 51.0 | — | 24.0 | 11.5 % | 26.1 % | 10.5 % | 42.1 % | 15.9 % | 0.11 | 53.8 % | +16.9 % | 0.0 % | 0.0 % | 9.3 | 96.9 % | 8.6 % | — |
| RAPP Rapport Therapeutics, Inc. Common | 08/06 | — | 55 5/22 | Stage 2 | D -34 | 4 of 9 | 1.8 | Biotechnology | – | — | — | Healthcare | 40.20 $ | +28.1 % | +30.6 % | +267.7 % | −8.0 % | +45.6 % | 92 | 42 | 6.0 % | 6.1 % | 0.95 | — | 0.0 | 91.6 | 4.0 | — | — | 0.0 | — | 34.3 % | 0.0 % | -28.3 % | -19.1 % | 0.02 | — | — | 0.0 % | 0.0 % | 25.1 | 109.6 % | 7.5 % | — |
| ROIV Roivant Sciences Ltd | 08/10 | +76 % | 38 4/22 | Stage 2 | D -13 | 3 of 9 | 23.8 | Biotechnology | Uses AI | — | — | Healthcare | 34.10 $ | +48.4 % | +54.4 % | +195.7 % | −1.9 % | +14.8 % | 91 | 2 | 3.9 % | 4.0 % | 1.11 | — | 0.0 | 2,867.0 | 5.4 | — | — | 0.7 | -14,675.1 % | -8,159.0 % | 0.0 % | -7.6 % | -14.4 % | 0.02 | 79.0 % | -71.6 % | 0.0 % | 0.0 % | 19.2 | 75.9 % | 6.1 % | 1.1 (10) |
| KRYS Krystal Biotech Inc | 08/03 | +62 % | 53 5/22 | Stage 2 | A +60 | 7 of 9 | 10.7 | Biotechnology | Uses AI | — | — | Healthcare | 339.20 $ | +38.0 % | +50.5 % | +152.1 % | −0.7 % | -2.8 % | 91 | 78 | 4.2 % | 3.9 % | 0.50 | 49.3 | 49.5 | 25.8 | 8.3 | 45.3 | — | 55.3 | 46.1 % | 94.2 % | 53.9 % | 19.9 % | 9.0 % | 0.01 | 91.4 % | +33.9 % | 0.0 % | 0.0 % | 19.8 | 99.4 % | 17.5 % | 1.1 (11) |
| COCO Vita Coco Company Inc | 07/29 | +64 % | — | Stage 2 | B +39 | 6 of 9 | 0.0 | Beverages - Non-Alcoholic | – | — | — | Consumer Defensive | 73.90 $ | +56.1 % | +35.8 % | +130.0 % | −3.8 % | -9.0 % | 91 | 50 | 4.8 % | 4.2 % | 0.76 | 60.1 | 28.8 | — | 13.4 | — | — | 36.6 | 18.7 % | 37.4 % | 12.6 % | 26.3 % | 13.9 % | 0.04 | 72.1 % | +18.2 % | 0.0 % | 0.0 % | 13.5 | 96.2 % | 9.9 % | 1.5 (10) |
| GHM Graham Corporation | 08/04 | +251 % | — | Stage 2 | C +9 | 1 of 9 | 0.0 | Specialty Industrial Machinery | – | — | — | Industrials | 105.10 $ | +70.9 % | +69.7 % | +138.3 % | −1.0 % | +6.4 % | 91 | 50 | 6.2 % | 6.7 % | 1.01 | — | 58.8 | — | — | — | 3.26 | 59.6 | 1.3 % | 23.6 % | 5.1 % | 9.6 % | 3.4 % | — | 43.4 % | +16.9 % | 0.0 % | 0.0 % | 5.4 | 80.2 % | 4.6 % | 1.2 (5) |
| LIND Lindblad Expeditions Holdings Inc | 08/03 | +50 % | 43 6/31 | Stage 2 | B +32 | 8 of 9 | 1.9 | Travel Services | – | — | — | Consumer Cyclical | 27.60 $ | +78.7 % | +94.4 % | +143.1 % | −1.1 % | -9.8 % | 91 | 94 | 5.8 % | 5.4 % | 2.23 | — | 217.4 | 2.4 | 159.8 | 22.7 | — | 22.2 | 7.5 % | 46.0 % | -3.1 % | -1,946.9 % | 3.8 % | -3.50 | -19.3 % | +19.6 % | 0.0 % | 0.0 % | 1.3 | 75.0 % | 10.9 % | 1.3 (3) |
| INDV Indivior PLC Ordinary Shares | 07/30 | +25 % | 68 6/22 | Stage 2 | B +22 | 4 of 9 | 4.7 | Drug Manufacturers - Special | Neutral | — | Healthcare | 39.10 $ | +11.4 % | +14.1 % | +197.3 % | −1.9 % | +23.1 % | 90 | 83 | 3.6 % | 3.6 % | 1.15 | 21.5 | 13.0 | 3.6 | 145.3 | — | — | 14.2 | 46.1 % | 85.0 % | 19.5 % | 12.2 % | 22.7 % | -3.49 | -12.0 % | +4.3 % | 0.0 % | 0.0 % | 3.6 | 107.5 % | 11.9 % | 1.0 (7) | |
| ATEN A10 Network | 08/04 | +48 % | 92 10/25 | Stage 2 | B +27 | 7 of 9 | 2.5 | Software - Infrastructure | – | — | — | Technology | 35.80 $ | +92.3 % | +102.9 % | +89.9 % | −1.3 % | +0.2 % | 90 | 71 | 4.1 % | 4.3 % | 1.14 | — | 51.0 | 8.4 | — | 48.8 | 14.76 | 30.9 | 17.3 % | 79.3 % | 14.9 % | 21.4 % | 5.2 % | — | 34.8 % | +11.0 % | 0.7 % | 25.5 % | 7.7 | 103.9 % | 12.1 % | 1.3 (6) |
Price Chart
Quarterly Figures
No quarterly data available.
Frequently Asked Questions
All-Time High: shows stocks currently trading at their all-time high — no more than 2% below it. The all-time high is measured over the complete available price history (as far back as data exists, currently to 2021). Stocks above their all-time high have no old price resistance left overhead; every holder is in the green.
All scanners are recalculated daily across the entire stock universe — most recently on 21. July 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).
Currently, 134 stocks pass this scanner's criteria (as of 21. July 2026). The 25 strongest hits are shown.
Global filters: 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.
Related scanners
- Ants
- Ben Bennett: Power of Four
- Bullish Reversal Bar
- Gap-Up (≥3%)
- Green Line Breakout
- High ADR — Hot Theme
- Inside Day
- Inside Day at Highs
- Mark Minervini: Power Play
- Oliver Kell: Bull Snorts
- Oliver Kell: Gappers
- Oops Reversal
- Pocket Pivot
- Pradeep Bonde: $ Breakout Bullish
- Pradeep Bonde: 4% Breakout Bullish
- Qullamaggie: Continuation Base
- Qullamaggie: Episodic Pivot
- Qullamaggie: High Tight Flag
- Strong DCR (≥80)
- Tight & Near High
- Tight Weekly Closes
- Tight Weekly Range (WCR≥90)
- Volume Surge
- Volume Surge
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.